Clinical Trial

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-08.
Trial Details
NCT Number NCT06590896
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Epilepsies, Partial
Enrollment 100 participants
Start Date 2022-11-04
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-03